Rizatriptan Benzoate
NDC Package 69097-182-65

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Rizatriptan Benzoate is a . Marketed by Cipla Usa Inc., this product is identified by NDC 69097-182 and is authorized under FDA application ANDA077526.

Identification & Billing

NDC Package Code
69097-182-65
Package Description
12 TABLET in 1 BOTTLE
Product Code
69097-182
11-Digit Billing Format
69097018265
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
12 EA

Clinical Specifications

Proprietary Name
Rizatriptan Benzoate
Dosage Form
-

Regulatory & Marketing

Labeler Name
Cipla Usa Inc.
FDA Application #
ANDA077526
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-20-2015
End Marketing Date
01-21-2020
Listing Expiration
01-21-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69097-182). Click a package code to view its specific billing and regulatory data.

69097-182-66
18 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69097-182-65 identifies a specific commercial package of 12 tablet in 1 bottle of Rizatriptan Benzoate, labeled by Cipla Usa Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cipla Usa Inc. on March 20, 2015. The current certification is valid through January 21, 2020.

How is this Cipla Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69097018265. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 12 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69097-182-65
11-Digit CMS (5-4-2)
69097-0182-65

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.